BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 15905936)

  • 1. [Visual acuity and full-field electroretinography in patients with Usher's syndrome].
    Mendieta L; Berezovsky A; Salomão SR; Sacai PY; Pereira JM; Fantini SC
    Arq Bras Oftalmol; 2005; 68(2):171-6. PubMed ID: 15905936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Usher's syndrome--case report.
    Kwiecień S; Sulak R; Szaflik J
    Klin Oczna; 2008; 110(10-12):384-6. PubMed ID: 19195172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Full-field electroretinography, visual acuity and visual fields in Usher syndrome: a multicentre European study.
    Stingl K; Kurtenbach A; Hahn G; Kernstock C; Hipp S; Zobor D; Kohl S; Bonnet C; Mohand-Saïd S; Audo I; Fakin A; Hawlina M; Testa F; Simonelli F; Petit C; Sahel JA; Zrenner E
    Doc Ophthalmol; 2019 Oct; 139(2):151-160. PubMed ID: 31267413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A rare type of Usher's syndrome.
    Antunica AG; Kastelan S; Bućan K; Ivanković M; Radman M; Karaman K
    Acta Clin Croat; 2013 Dec; 52(4):506-14. PubMed ID: 24697003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new clinical classification for Usher's syndrome based on a new subtype of Usher's syndrome type I.
    Otterstedde CR; Spandau U; Blankenagel A; Kimberling WJ; Reisser C
    Laryngoscope; 2001 Jan; 111(1):84-6. PubMed ID: 11192904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Estimation of morphology and function of the eye in Usher's syndrome].
    Mrugacz M; Szumiński M; Sredzińska-Kita D; Bakunowicz-Łazarczyk A
    Klin Oczna; 2010; 112(10-12):324-7. PubMed ID: 21473085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of topical dorzolamide and ketorolac treatment for cystoid macular edema in retinitis pigmentosa and Usher's syndrome.
    Lemos Reis RF; Moreira-Gonçalves N; Estrela Silva SE; Brandão EM; Falcão-Reis FM
    Ophthalmologica; 2015; 233(1):43-50. PubMed ID: 25428176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of foveal lesions in type 1 and type 2 Usher's syndrome.
    Fishman GA; Anderson RJ; Lam BL; Derlacki DJ
    Arch Ophthalmol; 1995 Jun; 113(6):770-3. PubMed ID: 7786220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is there genetic heterogeneity in Usher's syndrome?
    Matthews TW; Poliquin J; Mount J; MacFie D
    J Otolaryngol; 1987 Mar; 16(2):61-6. PubMed ID: 3599157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The incidence of Usher's syndrome and its clinical types].
    Bereketoğlu M; Avşar EU; Turan O; Afrashi F; Apaydin F
    Kulak Burun Bogaz Ihtis Derg; 2002; 9(1):15-20. PubMed ID: 12122620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A rare brain developmental anomaly in a patient with Usher's syndrome.
    Demir HD; Deniz FE; Yardim H
    Int Ophthalmol; 2010 Feb; 30(1):85-8. PubMed ID: 19005619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Usher's syndrome: electrophysiological tests of the visual and auditory systems.
    Abraham FA; Cohen D; Sohmer H
    Doc Ophthalmol; 1977 Dec; 44(2):435-44. PubMed ID: 598276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Yearly rates of rod and cone functional loss in retinitis pigmentosa and cone-rod dystrophy.
    Birch DG; Anderson JL; Fish GE
    Ophthalmology; 1999 Feb; 106(2):258-68. PubMed ID: 9951474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polyunsaturated fatty acids are lower in blood lipids of Usher's type I but not Usher's type II.
    Maude MB; Anderson EO; Anderson RE
    Invest Ophthalmol Vis Sci; 1998 Oct; 39(11):2164-6. PubMed ID: 9761296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The combination of vestibular impairment and congenital sensorineural hearing loss predisposes patients to ocular anomalies, including Usher syndrome.
    Kletke S; Batmanabane V; Dai T; Vincent A; Li S; Gordon KA; Papsin BC; Cushing SL; Héon E
    Clin Genet; 2017 Jul; 92(1):26-33. PubMed ID: 27743452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term follow-up of retinitis pigmentosa patients with multifocal electroretinography.
    Nagy D; Schönfisch B; Zrenner E; Jägle H
    Invest Ophthalmol Vis Sci; 2008 Oct; 49(10):4664-71. PubMed ID: 18566474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The RUSH2A Study: Best-Corrected Visual Acuity, Full-Field Electroretinography Amplitudes, and Full-Field Stimulus Thresholds at Baseline.
    Birch DG; Cheng P; Duncan JL; Ayala AR; Maguire MG; Audo I; Cheetham JK; Durham TA; Fahim AT; Ferris FL; Heon E; Huckfeldt RM; Iannaccone A; Khan NW; Lad EM; Michaelides M; Pennesi ME; Stingl K; Vincent A; Weng CY;
    Transl Vis Sci Technol; 2020 Oct; 9(11):9. PubMed ID: 33133772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Visual acuity loss in patients with Usher's syndrome.
    Piazza L; Fishman GA; Farber M; Derlacki D; Anderson RJ
    Arch Ophthalmol; 1986 Sep; 104(9):1336-9. PubMed ID: 3753284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Usher's syndrome. Ophthalmic and neuro-otologic findings suggesting genetic heterogeneity.
    Fishman GA; Kumar A; Joseph ME; Torok N; Anderson RJ
    Arch Ophthalmol; 1983 Sep; 101(9):1367-74. PubMed ID: 6604514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unanticipated prognosis for a patient with type 2 Usher syndrome.
    Vezinaw CM; Fishman GA; Chiang J
    Doc Ophthalmol; 2019 Apr; 138(2):161-166. PubMed ID: 30796641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.